Figure 1

![Figure 1: A PRISMA flow diagram traces the systematic literature search for studies of probiotics in C. difficile infection prevention, documenting records identified, screened, assessed for eligibility, and included in the meta-analysis.]()

> Source: Lynne V McFarland "Probiotics for the Primary and Secondary Prevention of C. difficile Infections: ." *Antibiotics (Basel, Switzerland)*, 2015. PMID: [27025619](https://pubmed.ncbi.nlm.nih.gov/27025619/)

<figure>
  <img src="" alt="A PRISMA flow diagram traces the systematic literature search for studies of probiotics in C. difficile infection prevention, documenting records identified, screened, assessed for eligibility, and included in the meta-analysis." />
  <figcaption>Figure 1. A PRISMA flow diagram traces the systematic literature search for studies of probiotics in C. difficile infection prevention, documenting records identified, screened, assessed for eligibility, and included in the meta-analysis.<br>  Source: Lynne V McFarland "Probiotics for the Primary and Secondary Prevention of C. difficile Infections: ." <em>Antibiotics (Basel, Switzerland)</em>, 2015. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27025619/">27025619</a></figcaption>
</figure>